Treatment of Autoimmune Hepatitis in Chronic Viral Hepatitis with Autoimmune Features

When autoimmune hepatitis presents in the context of chronic viral hepatitis with autoimmune features, clinical management involves addressing both the underlying viral infection and the autoimmune component of liver disease. This overlap scenario requires a carefully sequenced approach.

Clinical scenario

This protocol applies to patients with chronic viral hepatitis and autoimmune features — a population in which autoimmune hepatitis occurs alongside active or prior viral liver disease. The coexistence of these conditions shapes both the diagnostic evaluation and the treatment strategy.

Treatment approach — partial overview

Management begins with antiviral therapy directed at the chronic viral hepatitis. Depending on the hepatic response achieved, an additional treatment layer targeting liver inflammation may be considered — the full protocol details the criteria and sequencing for this step.

Complete regimen, decision criteria, and full sequencing available via the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

Patients with chronic viral hepatitis and autoimmune features should receive antiviral therapy (LoE 4, strong recommendation, strong consensus).
Immunosuppressive treatment is recommended if there is evidence of persistent liver inflammation despite adequate viral control (LoE 4, strong recommendation, strong consensus).

DOI: 10.1016/j.jhep.2025.03.017

View source ↗